- $929.42m
- $1.21bn
- $511.43m
U.S. RESEARCH ROUNDUP-Aclaris Therapeutics, Beauty Health Co, Vicarious Surgical
U.S. STOCKS ON THE MOVE-Walmart, Lyft, CrowdStrike
Brief: N-Able Announces Third Quarter 2023 Results
Brief: N-Able Q3 EPS USD 0.03
N-Able Inc reports results for the quarter ended in June - Earnings Summary
Brief: N-Able Q2 EPS USD 0.02
N-Able Inc expected to post earnings of 7 cents a share - Earnings Preview
Brief: N-Able Collaborates With Jcdc To Help Create A More Secure Global Msp Ecosystem
N-Able Inc reports results for the quarter ended in March - Earnings Summary
Brief: N-Able Announces First Quarter 2023 Results
Brief: N-Able sees Outlook Q2 revenue USD 102.5-103 million
N-Able Inc expected to post earnings of 7 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Terns Pharma, Rivian, Intel, Micron
U.S. STOCKS ON THE MOVE-Nikola, Cintas, Seagate
U.S. STOCKS ON THE MOVE-N-Able Inc, major U.S. banks, Lululemon Athletica Inc
N-able rises as co set to join S&P SmallCap index
N-Able Inc reports results for the quarter ended in December - Earnings Summary
Brief: N-Able Posts Q4 Operating Income Of $14.309 Million
Brief: N-Able Announces Fourth Quarter And Full-Year 2022 Results